These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 9062369)

  • 1. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.
    Ilan Y; Prakash R; Davidson A; Jona ; Droguett G; Horwitz MS; Chowdhury NR; Chowdhury JR
    J Clin Invest; 1997 Mar; 99(5):1098-106. PubMed ID: 9062369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenoviruses.
    Ilan Y; Sauter B; Chowdhury NR; Reddy BV; Thummala NR; Droguett G; Davidson A; Ott M; Horwitz MS; Chowdhury JR
    Hepatology; 1998 May; 27(5):1368-76. PubMed ID: 9581693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats.
    Ilan Y; Attavar P; Takahashi M; Davidson A; Horwitz MS; Guida J; Chowdhury NR; Chowdhury JR
    J Clin Invest; 1996 Dec; 98(11):2640-7. PubMed ID: 8958229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period.
    Takahashi M; Ilan Y; Chowdhury NR; Guida J; Horwitz M; Chowdhury JR
    J Biol Chem; 1996 Oct; 271(43):26536-42. PubMed ID: 8900123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat.
    Ilan Y; Jona VK; Sengupta K; Davidson A; Horwitz MS; Roy-Chowdhury N; Roy-Chowdhury J
    Hepatology; 1997 Oct; 26(4):949-56. PubMed ID: 9328318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome.
    Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR
    Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats.
    Sauter BV; Parashar B; Chowdhury NR; Kadakol A; Ilan Y; Singh H; Milano J; Strayer DS; Chowdhury JR
    Gastroenterology; 2000 Nov; 119(5):1348-57. PubMed ID: 11054394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression.
    Ilan Y; Droguett G; Chowdhury NR; Li Y; Sengupta K; Thummala NR; Davidson A; Chowdhury JR; Horwitz MS
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2587-92. PubMed ID: 9122239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral tolerance: a new tool for the treatment of gastrointestinal inflammatory disorders and liver-directed gene therapy.
    Ilan Y
    Can J Gastroenterol; 1999 Dec; 13(10):829-35. PubMed ID: 10625324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase.
    Askari FK; Hitomi Y; Mao M; Wilson JM
    Gene Ther; 1996 May; 3(5):381-8. PubMed ID: 9156798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat.
    Aubert D; Ménoret S; Chiari E; Pichard V; Durand S; Tesson L; Moullier P; Anegon I; Ferry N
    Mol Ther; 2002 Apr; 5(4):388-96. PubMed ID: 11945065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1.
    Li Q; Murphree SS; Willer SS; Bolli R; French BA
    Hum Gene Ther; 1998 Mar; 9(4):497-505. PubMed ID: 9525311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAPS Prize--1997. Fetal gene therapy: efficacy, toxicity, and immunologic effects of early gestation recombinant adenovirus. British Association of Paediatric Surgeons.
    Yang EY; Cass DL; Sylvester KG; Wilson JM; Adzick NS
    J Pediatr Surg; 1999 Feb; 34(2):235-41. PubMed ID: 10052795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats.
    Jia Z; Dankó I
    Hum Gene Ther; 2005 Aug; 16(8):985-95. PubMed ID: 16076256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies.
    Tominaga K; Kuriyama S; Yoshiji H; Deguchi A; Kita Y; Funakoshi F; Masaki T; Kurokohchi K; Uchida N; Tsujimoto T; Fukui H
    Gut; 2004 Aug; 53(8):1167-73. PubMed ID: 15247187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.
    Gahéry-Ségard H; Molinier-Frenkel V; Le Boulaire C; Saulnier P; Opolon P; Lengagne R; Gautier E; Le Cesne A; Zitvogel L; Venet A; Schatz C; Courtney M; Le Chevalier T; Tursz T; Guillet JG; Farace F
    J Clin Invest; 1997 Nov; 100(9):2218-26. PubMed ID: 9410899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector.
    Toietta G; Mane VP; Norona WS; Finegold MJ; Ng P; McDonagh AF; Beaudet AL; Lee B
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):3930-5. PubMed ID: 15753292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient expression of genes delivered to newborn rat liver using recombinant adeno-associated virus 2/8 vectors.
    Flageul M; Aubert D; Pichard V; Nguyen TH; Nowrouzi A; Schmidt M; Ferry N
    J Gene Med; 2009 Aug; 11(8):689-96. PubMed ID: 19455564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of Gunn rats with autologous fibroblasts expressing bilirubin UDP-glucuronosyltransferase: correction of genetic deficiency and tumor formation.
    Seppen J; Tada K; Ottenhoff R; Sengupta K; Chowdhury NR; Chowdhury JR; Bosma PJ; Oude Elferink RP
    Hum Gene Ther; 1997 Jan; 8(1):27-36. PubMed ID: 8989992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.
    Mack CA; Song WR; Carpenter H; Wickham TJ; Kovesdi I; Harvey BG; Magovern CJ; Isom OW; Rosengart T; Falck-Pedersen E; Hackett NR; Crystal RG; Mastrangeli A
    Hum Gene Ther; 1997 Jan; 8(1):99-109. PubMed ID: 8989999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.